- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15:06 | NeOnc Technologies Holdings, Inc.: NeOnc Technologies Reports Updated Clinical Results | 51 | GlobeNewswire (Europe) | CALABASAS, Calif., Dec. 15, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) ("NeOnc" or the "Company"), a multi-Phase 2 clinical-stage biopharmaceutical company developing... ► Artikel lesen | |
| Sa | NEONC TECHNOLOGIES HOLDINGS, INC. - S-1, General form for registration of securities | - | SEC Filings | ||
| 05.12. | NEONC TECHNOLOGIES HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 01.12. | Ultraschall steigert Wirksamkeit der Hirntumor-Therapie NEO100 von NeOnc | 1 | Investing.com Deutsch | ||
| NEONC TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 01.12. | NeOnc's NEO100 shows enhanced brain tumor treatment with ultrasound | 1 | Investing.com | ||
| 01.12. | NeOnc Technologies Holdings, Inc.: NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors | 1 | GlobeNewswire (USA) | ||
| 14.11. | NeOnc Technologies Holdings GAAP EPS of -$0.45 | 1 | Seeking Alpha | ||
| 14.11. | NeOnc Technologies Holdings, Inc.: NeOnc Technologies Holdings Reports Third Quarter 2025 Results and Provides Operational Update | 266 | GlobeNewswire (Europe) | CALABASAS, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) ("NeOnc" or the "Company"), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies... ► Artikel lesen | |
| 14.11. | NEONC TECHNOLOGIES HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 13.11. | NeOnc Technologies Holdings, Inc.: NeOnc Technologies Completes Enrollment in Pivotal NEO100 Phase2a Trial for IDH-1 mutant Recurrent High-Grade Glioma and Expects Interim Data Readout in SixMonths (Q22026) | 179 | GlobeNewswire (Europe) | CALABASAS, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) ("NeOnc" or the "Company"), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering... ► Artikel lesen | |
| 06.11. | NEONC TECHNOLOGIES HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 04.11. | NeOnc Technologies Holdings, Inc.: NeOnc Technologies Appoints Amir Heshmatpour as Chief Executive Officer to Drive Next Phase of Clinical and Corporate Growth | 1 | GlobeNewswire (USA) | ||
| 30.10. | NEONC TECHNOLOGIES HOLDINGS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 28.10. | NeOnc Technologies Holdings, Inc.: His Highness Sheikh Nahyan bin Zayed Al Nahyan Assumes Executive Chairmanship of NeOnc Technologies' Subsidiary, NuroMENA, Pioneering UAE-US Partnership in Brain Cancer Treatment | 190 | GlobeNewswire (Europe) | CALABASAS, Calif. and ABU DHABI, United Arab Emirates, Oct. 28, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) ("NeOnc" or the "Company"), a multi-Phase 2 clinical-stage biopharmaceutical... ► Artikel lesen | |
| 09.10. | NeOnc Technologies schließt Forschungsabkommen in den VAE und erweitert Vorstand | 1 | Investing.com Deutsch | ||
| 09.10. | NeOnc Technologies signs UAE research agreement, expands board | 2 | Investing.com | ||
| 09.10. | NEONC TECHNOLOGIES HOLDINGS, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 09.10. | NeOnc Technologies Holdings, Inc.: NeOnc Technologies' Subsidiary, NuroMENA, Signs Master Services Agreement with M42's IROS and Expands Board of Directors | 1 | GlobeNewswire (USA) | ||
| 07.10. | New to The Street to Broadcast Tonight on Fox Business 10:30 PM PST Featuring NeOnc Technologies, FLOKI, XION, Sharps Technology, and Aeries Technology | 350 | ACCESS Newswire | NEW YORK CITY, NEW YORK / ACCESS Newswire / October 6, 2025 / New to The Street, one of America's longest-running business television brands, announces tonight's nationwide broadcast on Fox Business... ► Artikel lesen | |
| 06.10. | NeOnc Technologies Holdings, Inc.: NeOnc Technologies and Quazar Investment Set to Close $50 Million Strategic Partnership by October 23rd Following Final UAE Tax Approvals | 1 | GlobeNewswire (USA) |
1 2 3 4 Weiter >>
70 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 38,335 | -0,70 % | JEFFERIES stuft QIAGEN NV auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Qiagen mit einem Kursziel von 57 US-Dollar auf "Buy" belassen. Die Profitabilität dürfte 2026 zumindest stabil bleiben... ► Artikel lesen | |
| IMMUNOME | 23,480 | +19,67 % | Immunome's desmoid tumor treatment triumphs in phase 3, setting up approval filing | ||
| RADIOPHARM THERANOSTICS | 10,840 | +167,65 % | Radiopharm (RADX) Sees Slight Pessimism From Analysts | ||
| KYVERNA THERAPEUTICS | 10,820 | +23,23 % | Kyverna Therapeutics, Inc.: Kyverna Therapeutics Announces Positive Topline Data from Registrational KYSA-8 Trial of Miv-cel (KYV-101) in Stiff Person Syndrome | Landmark results could pave the way for miv-cel to become the first FDA-approved CAR T-cell therapy for autoimmune disease; Company on track to submit BLA for stiff person syndrome in 1H 2026 Miv-cel... ► Artikel lesen | |
| ARTIVA BIOTHERAPEUTICS | 5,920 | +80,49 % | Artiva Biotherapeutics, Inc. - 8-K, Current Report | ||
| OLEMA PHARMACEUTICALS | 35,430 | +7,23 % | Olema Pharmaceuticals stock price target raised to $45 at H.C. Wainwright | ||
| VERA THERAPEUTICS | 50,07 | +0,57 % | Vera Therapeutics, Inc. - 8-K, Current Report | ||
| BIONTECH | 80,10 | -0,87 % | Lungenkrebs-Präparat: Studiendaten schieben Biontech an | Die Aktie von BioNTech startet mit frischem Schwung in die Woche und verbucht bis zum Mittag ein Kursplus von gut drei Prozent. Auslöser sind ermutigende Studiendaten zu einem neuen Wirkstoffkandidaten... ► Artikel lesen | |
| PRAXIS PRECISION MEDICINES | 276,20 | +2,69 % | Praxis Precision Medicines, Inc.: Praxis Precision Medicines Announces Plans to File an NDA for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies in Early 2026 | BOSTON, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies... ► Artikel lesen | |
| KYMERA THERAPEUTICS | 85,50 | -4,65 % | Kymera Therapeutics, Inc.: Kymera Therapeutics Announces Closing of Upsized $602 Million Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares | WATERTOWN, Mass., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines... ► Artikel lesen | |
| AVIDITY BIOSCIENCES | 71,76 | -0,10 % | Dyne upgraded at Oppenheimer on upcoming trial readout from Avidity | ||
| CLIMB BIO | 3,890 | +29,67 % | Climb Bio, Inc. - 8-K, Current Report | ||
| IMMUNOVANT | 25,960 | -1,78 % | Immunovant: 550-Millionen-Dollar-Kapitalerhöhung und neue Studiendetails | ||
| HARMONY BIOSCIENCES | 38,780 | -4,27 % | Harmony Biosciences Holdings, Inc.: Harmony Biosciences to Present Rare Epilepsy Data at the 36th International Epilepsy Congress | Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that it will present data from its rare epilepsy pipeline at the 36th International Epilepsy Congress (IEC) being held August 30... ► Artikel lesen | |
| COGENT BIOSCIENCES | 40,440 | -3,97 % | Cogent Biosciences, Inc.: Cogent Biosciences Announces Positive Top-line Results of APEX Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM) | -- Bezuclastinib demonstrated rapid and deep clinical benefit in AdvSM patients resulting in an objective response rate (CR+CRh+PR+CI) of 57% per mIWG criteria and 80% per PPR criteria -- -- Bezuclastinib... ► Artikel lesen |
Das Unternehmen NEONC TECHNOLOGIES HOLDINGS INC kann der Branche Biotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,075 (-0,73 %) liegt der Kurs bei 10,135 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEONC TECHNOLOGIES HOLDINGS INC finden Sie auf Wallstreet Online.